.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2013 for an immense $43...
.On the heels of a phase 3 win that neglected to impress investors, Ironwood Pharmaceuticals is back...
.Don't cease Monte Rosa Rehabs right now. The Boston-based biotech is actually enjoying after signin...
.Invite to this week's Chutes & Ladders, our roundup of considerable management hirings, firings ...
.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the ope...
.AbbVie has actually come back to the source of its antipsychotic goliath Vraylar searching for anot...
.GenSight Biologics is actually weeks far from running out of funds. Again. The biotech just possess...
.Monopar Therapeutics is actually bouncing back a medicine coming from the dump of AstraZeneca's unu...
.Along with brand new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of anal...
.After developing a genetics therapy relationship along with Dyno Therapeutics in 2020, Roche is bac...